|
|
News for Healthier Living
How a CRISPR Sickle Cell Therapy Moved From Lab to Clinical Trial
A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.
November 4, 2026
November 4 2026November 3 2026November 2 2026November 1 2026October 30 2026October 29 2026October 28 2026October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026October 22 2026October 21 2026
|
|
|
|
|